explains the palmitate synthesis- which is most common FA stored in Adipose tissue , elongation system and Desaturation system, compares oxidation with synthesis.
Cholesterol is the major sterol in the animal tissues.
Cholesterol is present in tissues and in plasma either as free cholesterol or as a storage form, combined with a long-chain fatty acid as cholesteryl ester.
In plasma, both forms are transported in lipoproteins
removed from tissues by plasma high-density lipoprotein (HDL) and transported to the liver, where it is eliminated from the body either unchanged or after conversion to bile acids in the process known as reverse cholesterol transport
the slides aim at providing explanations on cholesterol biosynthesis, regulations, functions of cholesterol, and their consequences. facts about lipoproteins have also been included. enjoy the reading
prepared by Asangalwisye Deo
St. john's University of Tanzania
explains the palmitate synthesis- which is most common FA stored in Adipose tissue , elongation system and Desaturation system, compares oxidation with synthesis.
Cholesterol is the major sterol in the animal tissues.
Cholesterol is present in tissues and in plasma either as free cholesterol or as a storage form, combined with a long-chain fatty acid as cholesteryl ester.
In plasma, both forms are transported in lipoproteins
removed from tissues by plasma high-density lipoprotein (HDL) and transported to the liver, where it is eliminated from the body either unchanged or after conversion to bile acids in the process known as reverse cholesterol transport
the slides aim at providing explanations on cholesterol biosynthesis, regulations, functions of cholesterol, and their consequences. facts about lipoproteins have also been included. enjoy the reading
prepared by Asangalwisye Deo
St. john's University of Tanzania
cholesterol introduction , synthesis , degradation and functions.
different intermediate products , biochemical importance, fate of cholesterol: synthesis of bile acids (primary and secondary ) , synthesis of vitamin D and different steroid hormones
clinical significance of cholesterol: Hypercholesterolemia ANd hypocholesterolemia normal ranges and so on
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptxRajendra Dev Bhatt
Cholesterol is found exclusively in animals, hence it is often called as animal sterol.
The total body content of cholesterol in an
adult man weighing 70 kg is about 140 g i.e., around 2 g/kg body weight.
The level of cholesterol in blood is related to the development of atherosclerosis & MI.
Steroids, Classification of Steroids, Cholesterol, Testosterone, Estrogen, Progesterone, Aldosterone, Significance, Biosynthesis, Skeleton structure, History, Bile acids, Cardiac Glycosides, Steroid hormones, Saponins, Mode of Action, Tests of steroids, Sterol, Adrenocorticosteroids, Glucocorticoids, Cortisol, Hydrocortisone, Prednisolone, Mineralocorticoids, Steroid Contraceptives, Androgens, Vitamin D2&D3, Cardenolides
All rights of images and videos are reserved to their rightful owners.
This presentation contains topic related to
CHOLESTEROL, CHOLESTEROL METABOLISM & CHOLESTEROL BIOSYNTHESIS.
Books referred: https://www.amazon.in/Biochemistry-2019-Satyanarayana-Satyanarayana-Author/dp/B07WGHCTKZ/ref=sr_1_1?dchild=1&qid=1591114482&refinements=p_27%3AU+Satyanarayana&s=books&sr=1-1
Cellular Energy Transfer (Glycolysis and Krebs Cycle) and ATPmuhammad aleem ijaz
This presentation is all about Cellular Energy Transfer with reference to Glycolysis and Kreb Cycle with all their stages involved.
It also includes ATP production in the body, its importance, structure.
Also contains a comparison of energy production in Krebs and Glycolysis cycle.
The presentation may give you an idea abouth the disease, its pathophysiology, signs, symptoms, diagnosis, treatment....Thanks toall the websites which helped me to make this presentation.
This presentation gives information about the antimetabolites and suicide inhibitors that we are frequently using. Their mechanism and various examples are also given
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
The increased availability of biomedical data, particularly in the public domain, offers the opportunity to better understand human health and to develop effective therapeutics for a wide range of unmet medical needs. However, data scientists remain stymied by the fact that data remain hard to find and to productively reuse because data and their metadata i) are wholly inaccessible, ii) are in non-standard or incompatible representations, iii) do not conform to community standards, and iv) have unclear or highly restricted terms and conditions that preclude legitimate reuse. These limitations require a rethink on data can be made machine and AI-ready - the key motivation behind the FAIR Guiding Principles. Concurrently, while recent efforts have explored the use of deep learning to fuse disparate data into predictive models for a wide range of biomedical applications, these models often fail even when the correct answer is already known, and fail to explain individual predictions in terms that data scientists can appreciate. These limitations suggest that new methods to produce practical artificial intelligence are still needed.
In this talk, I will discuss our work in (1) building an integrative knowledge infrastructure to prepare FAIR and "AI-ready" data and services along with (2) neurosymbolic AI methods to improve the quality of predictions and to generate plausible explanations. Attention is given to standards, platforms, and methods to wrangle knowledge into simple, but effective semantic and latent representations, and to make these available into standards-compliant and discoverable interfaces that can be used in model building, validation, and explanation. Our work, and those of others in the field, creates a baseline for building trustworthy and easy to deploy AI models in biomedicine.
Bio
Dr. Michel Dumontier is the Distinguished Professor of Data Science at Maastricht University, founder and executive director of the Institute of Data Science, and co-founder of the FAIR (Findable, Accessible, Interoperable and Reusable) data principles. His research explores socio-technological approaches for responsible discovery science, which includes collaborative multi-modal knowledge graphs, privacy-preserving distributed data mining, and AI methods for drug discovery and personalized medicine. His work is supported through the Dutch National Research Agenda, the Netherlands Organisation for Scientific Research, Horizon Europe, the European Open Science Cloud, the US National Institutes of Health, and a Marie-Curie Innovative Training Network. He is the editor-in-chief for the journal Data Science and is internationally recognized for his contributions in bioinformatics, biomedical informatics, and semantic technologies including ontologies and linked data.
This pdf is about the Schizophrenia.
For more details visit on YouTube; @SELF-EXPLANATORY;
https://www.youtube.com/channel/UCAiarMZDNhe1A3Rnpr_WkzA/videos
Thanks...!
2. CHOLESTEROL
Cholesterol is the major sterol in the animal tissue.
Cholesterol is an essential molecule in many animals, including
humans, but is not required in the human diet – all cells can
synthesize it from simple precursors.
Cholesterol plays a crucial role as a component of cellular membranes
and as a precursor of steroid hormones and bile acids.
The deposition of cholesterol in arteries has been associated with
cardiovascular disease and stroke.
In a healthy organism, an intricate balance is maintained between
the biosynthesis, utilization and transport of cholesterol , keeping in
harmful deposition to a minimum.
Total body content of cholesterol in an adult man weighing 70kg is
about 140g. i.e 2 g/Kg body weight.
3. It is a 27 – carbon compound.
It has a steroid nucleus, consisting of four fused rings, three with six
carbons and one with five.
It is amphipathic with a polar head group and a non polar
hydrocarbon body about as long as a 16 – carbon fatty acid in its
extended form.
4. The body transport fat and cholesterol by coating them
with a water soluble “ bubble” of protein called
lipoprotein.
Low density lipoprotein carry cholesterol to the
tissues. This is “bad cholesterol”, since high LDL
levels are linked to increased risk for heart disease.
High density lipoprotein carry excess cholesterol back
to the liver, which processes and excretes the
cholesterol. HDL’s are good cholesterol. The more
HDL you have, the lower your risk for heart disease.
HDL and LDL are found only in your blood and not
in the food.
5. It has a complex biosynthetic pathway.
All of its carbon atom are provided by a
single precursor – acetate.
Acetate was first converted to isoprene
units (c 5)
7. This highly complex pathway was
elucidated by Konrad Bloch, Feodar
Lynen, John Cornforth and George
Popjak in the late 1950s.
This pathway is a part of a branched
pathway that produces several other
essential isoprenoids in addition to
cholesterol, namely, ubiquinone,
dolichol, farnesylated proteins,
geranylgeranyated proteins and
isopentenyl adenosine.
8. Synthesis takes place in four stages.
Condensation of three acetate units to
form a six – carbon intermediate,
mevalonate.
Conversion of mevalonate to activated
isoprene units.
Polymerization of six 5-carbon
isoprene units to form the 30- carbon linear
squalene.
Cyclization of squalene to form the
four rings of the steroid nucleus.
9. 1. Synthesis of mevalonate from acetate
Two molecules of acetyl- CoA condense to
form acetoacetyl- CoA.
Acetoacetyl – CoA condense with a third
molecule of acetyl- CoA to yield the six carbon
compound β-hydroxy-β- methylglutaryl –
CoA(HMG- CoA).
Reduction of HMG-CoA to mevalonate.
10. 2. Conversion of mevalonate to two activated isoprenes.
Three phosphate groups are transferred
from three ATP molecules to mevalonate.
3-Phospho-5 pyrophosphomevalonate
formed is converted to ∆3 – isopentenyl
pyrophosphate.
∆3 – isopentenyl pyrophosphate isomerize
to yield the dimethylallyl pyrophosphate.
11. 3. Condensation of six activated isoprene units to form
Squalene
Isopentenyl pyrophosphate and
dimethylallyl pyrophosphate undergo a
head to tail condensation in which one
pyrophosphate group is displaced and a
10 - carbon chain, Geranyl
pyrophosphate is formed.
Geranyl pyrophosphate undergoes
another head to tail condensation with
isopentenyl pyrophosphate, yielding the
15-carbon intermediate farnesyl
pyrophosphate.
Finally two molecules of farnesyl
pyrophosphate join head to head with
the elimination of both pyrophoshate
groups, to form squalene.
12. 4. Conversion of squalene to the four ring steroid
nucleus.
The action of squalene monooxygenase
adds one oxygen atom from O2 to the end
of the squalene chain, forming an
epoxide.
This enzyme is another mixed- function
oxidase, NADPH reduces the other
oxygen atom of O2 to H2O.
The double bonds of the product,
squalene 2,3-epoxide are positioned so
that a remarkable concerted reaction can
convert the linear sequence epoxide to a
cyclic structure.
13. In animal cells, this cyclization
results in the formation of lanosterol,
which contains the four rings
characteristics of the steroid nucleus.
Lanosterol is finally converted to
cholesterol in a series of about 20
reactions that include the migration of
some methyl groups and the removal
of others.
14. Cholesterol is the sterol
characteristic to animals; plants,
fungi and protist make other
closely related sterols instead.
They use the same synthetic
pathways as far as squalene 2,3
– epoxide, at which point the
pathways diverge slightly such
as stigmasterol in plants and
ergosterol in fungi.
15. Regulation of cholesterol
biosynthesis
The rate-limiting step in the pathway to
cholesterol is the conversion of HMG-CoA to
mevalonate, the reaction catalyzed by HMG-CoA
reductase.
16. Regulation of cholesterol level by the
transcriptional regulation of the gene encoding
HMG - CoA Reductase.
This gene along with 20 other genes encoding enzymes are
a part of a small family of proteins called sterol regulatory
element binding proteins ( SREBPs).
When newly synthesized these proteins are embedded in
the ER, only soluble amino-terminal domain of an SREBP
functions as a transcriptional activator, this domain has
no access to the nucleus and cannot participate in gene
activation while it remains part of the SREBP molecule.
SREBP is secured to the ER in complex with another
protein called SREBP cleavage activation protein(SCAP).
It is SCAP that binds cholesterol thus acting as a sterol
sensor.
17. When cholesterol levels are high, SREBP are inactive, secured to the ER in a
complex with SCAP.
When cholesterol levels are low, the conformational change in SCAP causes
release of the SCAP-SREBP complex from the ER – retention activity and the
complex migrates within vesicles to the golgi complex.
In the Golgi complex the SREBP is cleaved twice by two different proteases
the second cleavage releasing the amino terminal domain into the cytosol.
18. This domain travels to the nucleus and activates transcription of its
target genes
The amino terminal domain of SREBP has a short half life and is
rapidly degraded by proteosomes.
When sterol levels increases sufficiently the proteolytic release of
SREBP amino terminal domain is again blocked and proteosome
degradation of the existing active domains results in a rapid shut down
of the gene targets.
19.
20. HORMONAL
CONTROL
Hormonal control is mediated by covalent modification
of HMG-CoA Reductase itself.
The enzyme exists in phosphorylated(inactive) as well
as dephosphorylated (active) forms.
Glucagon stimulates phosphorylation and insulin
promote dephosphorylation, activating the enzyme and
favoring cholesterol biosynthesis.
21. ATHEROSCLEROSIS
Unregulated cholesterol production can lead to
serious human disease.
When the sum of cholesterol synthesized and
cholesterol obtained in the diet exceeds the amount
required for the synthesis of membranes, bile salts,
steroids, pathological accumulations of cholesterol in
blood vessels can develop, resulting in the obstruction
of blood vessels